Northern Trust Corp Avrobio, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$1.15 - $1.48 $101 - $130	-88 Reduced 0.13%	67,442 $86,000
Q4 2023 Feb 13, 2024	SELL	$1.22 - $1.62 $8,446 - $11,215	-6,923 Reduced 9.3%	67,530 $91,000
Q3 2023 Nov 13, 2023	SELL	$0.98 - $1.62 $811 - $1,341	-828 Reduced 1.1%	74,453 $114,000
Q2 2023 Aug 11, 2023	SELL	$0.58 - $1.31 $106 - $241	-184 Reduced 0.24%	75,281 $71,000
Q1 2023 May 15, 2023	BUY	$0.76 - $1.82 $1,160 - $2,779	1,527 Added 2.07%	75,465 $75,000
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $186,018 - $329,871	-248,024 Reduced 77.04%	73,938 $68,000
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $29,768 - $93,227	-23,076 Reduced 6.69%	321,962 $425,000
Q4 2021 Feb 08, 2022	SELL	$3.45 - $6.05 $46,071 - $80,791	-13,354 Reduced 3.73%	345,038 $1.33 Million
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $88,739 - $148,916	-16,047 Reduced 4.29%	358,392 $2 Million
Q2 2021 Aug 13, 2021	SELL	$7.84 - $12.6 $207,697 - $333,799	-26,492 Reduced 6.61%	374,439 $3.33 Million
Q1 2021 May 12, 2021	BUY	$10.54 - $19.3 $121,884 - $223,185	11,564 Added 2.97%	400,931 $5.09 Million
Q4 2020 Feb 11, 2021	BUY	$12.79 - $17.1 $40,659 - $54,360	3,179 Added 0.82%	389,367 $5.43 Million
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $110,415 - $164,985	-8,500 Reduced 2.15%	386,188 $5.03 Million
Q2 2020 Aug 14, 2020	BUY	$12.19 - $22.96 $1.09 Million - $2.05 Million	89,207 Added 29.2%	394,688 $6.89 Million
Q1 2020 May 14, 2020	BUY	$10.08 - $27.21 $475,433 - $1.28 Million	47,166 Added 18.26%	305,481 $4.75 Million
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $172,586 - $289,363	13,225 Added 5.4%	258,315 $5.2 Million
Q3 2019 Nov 13, 2019	BUY	$14.12 - $23.44 $1.51 Million - $2.51 Million	107,149 Added 77.68%	245,090 $3.46 Million
Q2 2019 Aug 13, 2019	BUY	$13.21 - $27.29 $70,581 - $145,810	5,343 Added 4.03%	137,941 $2.24 Million
Q1 2019 May 13, 2019	BUY	$12.46 - $22.05 $665,202 - $1.18 Million	53,387 Added 67.4%	132,598 $2.92 Million
Q4 2018 Feb 12, 2019	BUY	$15.43 - $32.7 $33,483 - $70,959	2,170 Added 2.82%	79,211 $1.32 Million
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $1.84 Million - $3.59 Million	68,105 Added 762.14%	77,041 $4 Million
Q2 2018 Sep 18, 2018	BUY	$28.08 - $31.2 $250,922 - $278,803	8,936 New	8,936 $255,000

Others Institutions Holding AVRO

# of Institutions

Shares Held

559K

Call Options Held

Put Options Held

Terrapin Asset Management, LLC Miami, FL

559K
Shares

$0
0.98% of portfolio

View Full List

About AVROBIO, Inc.

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

More about AVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account